McDonald’s Adapts to Weight-Loss Trend with Protein-Focused Menu Items

McDonald’s is the latest fast food chain to respond to changing American eating habits driven by the rising use of GLP-1 weight-loss drugs, such as Ozempic and Wegovy. The company is testing protein-rich menu items to appeal to customers seeking higher-protein, lower-calorie meals. CEO Chris Kempczinski said during an earnings call that adoption of these medications is reshaping consumer behavior, with customers opting for more protein, fewer snacks, and reduced sugary beverages. “As adoption grows, we know that consumers’ behavior changes,” he said.

McDonald’s already offers protein-heavy options such as Snack Wraps, Sausage Biscuit sandwiches, and McCrispy Strips. Vice President Jill McDonald confirmed that the chain has long-term plans to cater to customers taking GLP-1 medications but did not reveal further details. Other chains have similarly adapted to the trend. Smoothie King launched a GLP-1-focused menu with high-protein, fiber-rich, and sugar-free smoothies. Olive Garden introduced lighter portion options, while Chipotle added a high-protein chicken cup. Subway and Shake Shack have also expanded protein-focused offerings.

GLP-1 medications, initially used for diabetes, have surged in popularity as weight-loss tools. A November 2025 Kaiser Family Foundation poll found 12% of Americans now take a GLP-1 drug, double the share reported in May.